Essentia Health

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Essentia Health sits in the top decile of US sponsors by registered trial count (#842 of 15,742 sponsors by registered trial count).

17 total trials 1 currently recruiting 11 completed early-phase tilt top decile by trial count

Essentia Health: 17 sponsored US clinical trials, 1 recruiting.

Essentia Health sponsors 17 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 11 completed. 1 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Cholesterol, Elevated, with 1 trials.

Top-decile sponsor footprint

Essentia Health ranks in the top decile of sponsors by registered trial count (#842 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 22/100

11 of 15 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (73.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

17 total, page 1 of 1

RECRUITING NA

Safety of Extending The Routine Flushing Of Implanted Port Devices From 4 Weeks To 12

NCT05454189

ACTIVE NOT RECRUITING Phase 3

Improved Diagnosis of Familial Hypercholesterolemia Across the Northland (ID-FH)

NCT05238519

COMPLETED Phase 2

Hyperbaric Oxygen Effects on Persistent Post-concussive Symptoms

NCT05173818

COMPLETED NA

Implementing Preemptive Pharmacogenomic Testing for Colorectal Cancer Patients in a Community Oncology Clinic

NCT03187184

TERMINATED Phase 2

Phase 2 Evaluation of Multi-modality Algorithm for Non-metastatic Adenocarcinoma of Pancreas or Ampulla

NCT02626520

COMPLETED

Risk Stratification of Patients Presenting With Cardiac Arrest

NCT02738099

TERMINATED

Activation Timing and Atrial Fibrillation

NCT02063191

TERMINATED Phase 2

Preventing Alcohol Withdrawal With Oral Baclofen

NCT01937364

COMPLETED

Study to Monitor Patients With Pacemakers or ICDs Who Undergo MRI Scans

NCT01999751

COMPLETED NA

The Impact of Dietary Restriction of Animal Protein and Fat on Osteoarthritis

NCT01939262

COMPLETED NA

Conformal Partial Breast Irradiation With CyberKnife After Resection for Early Stage Breast Cancer

NCT01290835

COMPLETED

Normal Tissue Oxygenation Following Radiotherapy

NCT00677040

COMPLETED

Community Based Self Management of COPD Facilitated by a Palliative Care Team:Impact on Health Care Utilization and QOL

NCT00648609

COMPLETED

CRM and Fusion Beats: Effects of Progressive Fusion on Intra-left Ventricular Mechanical Function

NCT00610896

TERMINATED NA

Zinc Sulfate in the Treatment of Rosacea: A Randomized, Controlled Trial

NCT00395226

COMPLETED

St. Mary's Duluth Clinic (SMDC) Pacemaker Magnetic Resonance Imaging (MRI) Study

NCT00631904

COMPLETED NA

Treating Alcohol Withdrawal With Oral Baclofen

NCT00597701

What is open in the Essentia Health pipeline

1 recruiting of 17 indexed (6% open); 11 completed (65%).

Phase mix: 1 late (III/IV) vs 3 early (I/II) (early-phase heavy).

Top condition: Cholesterol, Elevated (1 trial), 5 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Essentia Health: open-pipeline peers nationwide

Peers matched on 17 registered trials and 6% open enrollment, not the therapeutic-area sidebar.

Essentia Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 102030405060 0%5%10%15%20%25% Total trials Recruiting share Essentia HealthAchieve Life SciencesBioDelivery Sciences InternationalChugai PharmaceuticalConvaTecColgate PalmoliveDurham VA Medical CenterMadrigal PharmaceuticalsSouthern Methodist University
Essentia Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Essentia Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 17 trials (± recruiting share)

Sponsors near 6% open enrollment (± trial volume)

What to do with this Essentia Health page

17 registered trials is a research-attention snapshot, not an endorsement of Essentia Health or any single study.

  • 1 of Essentia Health's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Cholesterol, Elevated is the condition Essentia Health studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cholesterol, Elevated trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Essentia Health pipeline card: 17 registered trials from official public datasets.Report a data error.